CRISPR/Cas9-Mediated HKDC1 Depletion to Assess Ferroptosis and Lenvatinib Responses in Hepatocellular Carcinoma

Jiahao Sun, Pingyuan Tan, Yuting Shao, Zhihua Lu

Open source

DOI
10.3791/73461
Published
2026-09-25
Container
Journal of Visualized Experiments
Publisher
MyJove Corporation
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3791/73461,
  title = {CRISPR/Cas9-Mediated HKDC1 Depletion to Assess Ferroptosis and Lenvatinib Responses in Hepatocellular Carcinoma},
  author = {Jiahao Sun and Pingyuan Tan and Yuting Shao and Zhihua Lu},
  year = {2026},
  journal = {Journal of Visualized Experiments},
  doi = {10.3791/73461},
  url = {https://doi.org/10.3791/73461}
}

RIS

TY  - JOUR
TI  - CRISPR/Cas9-Mediated HKDC1 Depletion to Assess Ferroptosis and Lenvatinib Responses in Hepatocellular Carcinoma
AU  - Jiahao Sun
AU  - Pingyuan Tan
AU  - Yuting Shao
AU  - Zhihua Lu
PY  - 2026
JO  - Journal of Visualized Experiments
DO  - 10.3791/73461
UR  - https://doi.org/10.3791/73461
ER  - 

APA

Sun, J., Tan, P., Shao, Y., & Lu, Z. (2026). CRISPR/Cas9-Mediated HKDC1 Depletion to Assess Ferroptosis and Lenvatinib Responses in Hepatocellular Carcinoma. Journal of Visualized Experiments. https://doi.org/10.3791/73461

Source records